3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
5
Urothelial Carcinoma of the Bladder
1
Rhabdoid Tumor
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Choroid Plexus Neoplasms
1
Childhood Solid Tumor
1
Central Nervous System Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
13
Temozolomide
12
Specimen Handling
8
X-Rays
7
Biopsy
7
Nuclear Medicine Department, Hospital
6
Radiation
5
Phantoms, Imaging
5
trametinib
4
erdafitinib
4
dabrafenib
4
ulixertinib
3
larotrectinib
3
Radiotherapy
3
tipifarnib
2
selpercatinib
2
palbociclib
2
olutasidenib
2
olaparib
2
ivosidenib
2
ensartinib
2
binimetinib
2
Nivolumab
2
D2C7-(scdsFv)-PE38KDEL
2
vorasidenib
1
veliparib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
tazemetostat
1
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioma
×
Vinblastine
×
30 days
×
Clear all
No trials found.